Literature DB >> 30636997

Acute Limb Ischemia.

Hideaki Obara1, Kentaro Matsubara1, Yuko Kitagawa1.   

Abstract

Acute limb ischemia (ALI) is a rapid decrease in lower limb blood flow due to acute occlusion of peripheral artery or bypass graft, and in ALI not only limbs but also life prognosis will be poor unless quick and appropriate treatment is given. The etiology is broadly divided into embolism and thrombosis with various comorbidities. The symptoms of ALI are abrupt with pain, numbness, and coldness of lower limb, and paresthesia, contracture, and irreversible purpura will appear with the exacerbation of ischemia. Severity and treatment strategy should be determined based on physical findings and image findings. Considering life prognosis, limb amputation should be done without hesitation when the limb was diagnosed as irreversible. ALI can be treated by means of open surgical revascularization, endovascular, or hybrid approach with rapid systemic administration of heparin. In any cases, evaluating the lesions by intraoperative angiography and appropriate additional treatment are important. ALI is a serious disease requiring urgent treatment, and it is essential to promptly perform the best initial treatment that can be performed at each facility. (This is a translation of Jpn J Vasc Surg 2018; 27: 109-114.).

Entities:  

Keywords:  acute limb ischemia; embolectomy; endovascular treatment; hybrid therapy; thrombolysis

Year:  2018        PMID: 30636997      PMCID: PMC6326052          DOI: 10.3400/avd.ra.18-00074

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  8 in total

1.  Sudden development of the upper and lower limb ischemia as the first manifestation of COVID-19 infection.

Authors:  Shafagh Aliasgarzadeh; AmirAhmad Arabzadeh; Sepideh Fathibitaraf; Mohammad Negaresh
Journal:  Int J Surg Case Rep       Date:  2022-06-21

2.  Successful limb salvage by endovascular treatment for critical limb ischemia subsequent to acute limb ischemia.

Authors:  Tetsuya Nomura; Satoshi Tasaka; Kenshi Ono; Yu Sakaue; Naotoshi Wada; Natsuya Keira; Tetsuya Tatsumi
Journal:  Oxf Med Case Reports       Date:  2019-10-31

3.  The analysis for time of referral to a medical center among patients with diabetic foot infection.

Authors:  Cheng-Wei Lin; Hui-Mei Yang; Shih-Yuan Hung; I-Wen Chen; Yu-Yao Huang
Journal:  BMC Fam Pract       Date:  2021-01-09       Impact factor: 2.497

4.  Short- and Mid-Term Survival Prediction in Patients with Acute Type A Aortic Dissection Undergoing Surgical Repair: Based on the Systemic Immune-Inflammation Index.

Authors:  Zeshi Li; He Zhang; Sulaiman Baraghtha; Jiabao Mu; Yusanjan Matniyaz; Xinyi Jiang; Kuo Wang; Dongjin Wang; Yun Xing Xue
Journal:  J Inflamm Res       Date:  2022-10-10

5.  Macrophage-derived glutamine boosts satellite cells and muscle regeneration.

Authors:  Min Shang; Federica Cappellesso; Ricardo Amorim; Jens Serneels; Federico Virga; Guy Eelen; Stefania Carobbio; Melvin Y Rincon; Pierre Maechler; Katrien De Bock; Ping-Chih Ho; Marco Sandri; Bart Ghesquière; Peter Carmeliet; Mario Di Matteo; Emanuele Berardi; Massimiliano Mazzone
Journal:  Nature       Date:  2020-10-28       Impact factor: 49.962

6.  Acute limb ischemia in a patient with Covid-19 pneumonia: a case report.

Authors:  Ulfah Kartikasari; Susanthy Djajalaksana; Heny Martini
Journal:  J Thromb Thrombolysis       Date:  2021-04-01       Impact factor: 2.300

7.  Acute limb ischemia in a cancer patient has high morbidity, high mortality, and atypical presentation: a tertiary cancer center's retrospective study.

Authors:  Yolanda Bryce; Amoateng Emmanuel; Christopher Agrusa; Etay Ziv; Christopher Harnain; Samantha Huq; Ernesto Santos Martin
Journal:  BMC Cancer       Date:  2021-08-13       Impact factor: 4.430

8.  Comparison of digital subtraction angiography combined arterial thrombectomy versus simple arterial thrombectomy in the treatment of acute lower limb ischemia.

Authors:  Hongwei Ge; Bin Song; Xin Wang; Yunfeng Zhu; Yiming Huang; Weibin Huang; Yongbin Zhu
Journal:  BMC Surg       Date:  2021-07-15       Impact factor: 2.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.